UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000028099
Receipt No. R000032149
Scientific Title Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder
Date of disclosure of the study information 2017/07/06
Last modified on 2017/07/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder
Acronym Database study on cognitive behavioral therapy of the anxiety disorder
Scientific Title Observational epidemiology database study on cognitive behavioral therapy of the anxiety disorder
Scientific Title:Acronym Database study on cognitive behavioral therapy of the anxiety disorder
Region
Japan

Condition
Condition anxiety disorder
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 For the patients who received cognitive behavioral therapy of the anxiety disorder (social anxiety disorder(SAD), panic disorder(PD), obsessive compulsive disorder(OCD), PTSD), I collect the symptom with the structured interview and writing by oneself-style question paper and observational epidemiology data of the evaluation standard score of the QOL in the form that a study cooperator providing cognitive behavioral therapy inputs into WEB database and am intended that I analyze it in the place where enough majority cases gathered about the progress.
It is with valuable data for the spread if I can fix the system chasing the progress of the patient who received cognitive-behavioral therapy of the anxiety disorder by this study and thinks that it is significant.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Patient Health Questionnaire-9 :PHQ-9
Generalized Anxiety Disorder-7 :GAD-7
Working Alliance Inventory Short Form:WAI-SF

The main diagnosis
OCD: Yale-Brown Obsessive-Compulsive Scale :Y-BOCS
SAD: Liebowitz Social Anxiety Scale :LSAS
PD: Panic Disorder Severity Scale :PDSS
PTSD: Impact of Event Scale-Revised:IES-R

An investigation period is one year per one patient. The data are collected with following four points,from the point of the cognitive behavioral therapy of start, a midterm, the point of end, a start one year later.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1 Correspond to obsessive-compulsive disorder, panic disorder, society anxiety disorder, diagnostic criteria of the PTSD
:mental disease simple posture Creator interview The Mini-International Neuropsychiatric Interview:M.I.N.I. is based.

2 The age at agreement acquisition is less than 65 years old 16 years old or older. The sex does not matter.

3 A document agreement:give the case younger than 20 years to the person 16 years old or older, and the document of the protector agrees; by the free will of the person is provided in the one which understands it enough after having received enough explanation on participating of the final examination.

4 Can understand cognitive-behavioral therapy, and, for at least one year, can practice it continuously; is mental, and have a physical state.

5 Previous treatment, having medical therapy or not do not matter
Key exclusion criteria 1 The person that I am complicated with serious mental disorders such as the brain disorder (including dementia) of the tissue, a psychotic obstacle, bipolar disorder, the drug dependency, and interruption of the cognitive-behavioral therapy is expected for these symptom aggravation.
2 The person that interruption of the cognitive-behavioral therapy is expected to have the risk of the urgent suicide.
3 The person that interruption of the cognitive-behavioral therapy is expected because I repeat an antisocial act.
4 The person that interruption of the cognitive-behavioral therapy is expected to have a serious progressive physical disease.
5 The person who has difficulty in contact with the researcher.
6 The person who, in addition, judged it though a study person in charge or a study partaker carried out the final examination safely if was inappropriate.
Target sample size 210

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Eiji Shimizu
Organization Graduate School of Medicine Chiba University,Chiba University Hospital
Division name Research Center for Child Mental Development, Department of Cognitive Behavioral Physiology,Cognitive Behavioral Therapy Center
Zip code
Address 1-8-1 Inohana, Chuouku, Chiba, Japan
TEL 043-226-2027
Email eiji@faculty.chiba-u.jp

Public contact
Name of contact person
1st name
Middle name
Last name Eiji Shimizu
Organization Graduate School of Medicine Chiba University
Division name Department of Cognitive Behavioral Physiology
Zip code
Address 1-8-1 Inohana, Chuouku, Chiba, Japan
TEL 043-226-2027
Homepage URL
Email eiji@faculty.chiba-u.jp

Sponsor
Institute Graduate School of Medicine Chiba University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2017 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Observational study design
A.A direction of the data acquisition: The kind of the forward ;that but I turn my back and am possible after having obtained consent from a patient when data already exist.

B. study: It is a study of running, a cohort study

Management information
Registered date
2017 Year 07 Month 06 Day
Last modified on
2017 Year 07 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032149

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.